Annual Total Assets
$3.25 B
+$882.70 M+37.27%
31 December 2023
Summary:
Neurocrine Biosciences annual total assets is currently $3.25 billion, with the most recent change of +$882.70 million (+37.27%) on 31 December 2023. During the last 3 years, it has risen by +$1.52 billion (+87.43%). NBIX annual total assets is now at all-time high.NBIX Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$3.54 B
+$230.00 M+6.96%
30 September 2024
Summary:
Neurocrine Biosciences quarterly total assets is currently $3.54 billion, with the most recent change of +$230.00 million (+6.96%) on 30 September 2024. Over the past year, it has increased by +$686.80 million (+24.11%). NBIX quarterly total assets is now at all-time high.NBIX Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBIX Total Assets Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +37.3% | +24.1% |
3 y3 years | +87.4% | +75.2% |
5 y5 years | +227.4% | +199.6% |
NBIX Total Assets High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +87.4% | at high | +76.3% |
5 y | 5 years | at high | +227.4% | at high | +199.6% |
alltime | all time | at high | +4491.2% | at high | >+9999.0% |
Neurocrine Biosciences Total Assets History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $3.54 B(+7.0%) |
June 2024 | - | $3.31 B(-4.8%) |
Mar 2024 | - | $3.47 B(+6.8%) |
Dec 2023 | $3.25 B(+37.3%) | $3.25 B(+14.2%) |
Sept 2023 | - | $2.85 B(+9.0%) |
June 2023 | - | $2.61 B(+10.7%) |
Mar 2023 | - | $2.36 B(-0.4%) |
Dec 2022 | $2.37 B(+14.3%) | $2.37 B(+10.5%) |
Sept 2022 | - | $2.14 B(+6.9%) |
June 2022 | - | $2.01 B(-6.5%) |
Mar 2022 | - | $2.14 B(+3.5%) |
Dec 2021 | $2.07 B(+19.5%) | $2.07 B(+2.7%) |
Sept 2021 | - | $2.02 B(+3.1%) |
June 2021 | - | $1.96 B(+6.0%) |
Mar 2021 | - | $1.85 B(+6.4%) |
Dec 2020 | $1.73 B(+32.8%) | $1.73 B(+15.4%) |
Sept 2020 | - | $1.50 B(-0.9%) |
June 2020 | - | $1.52 B(+11.3%) |
Mar 2020 | - | $1.36 B(+4.3%) |
Dec 2019 | $1.31 B(+31.5%) | $1.31 B(+10.7%) |
Sept 2019 | - | $1.18 B(+10.6%) |
June 2019 | - | $1.07 B(+11.4%) |
Mar 2019 | - | $957.72 M(-3.6%) |
Dec 2018 | $993.15 M(+21.5%) | $993.15 M(+6.4%) |
Sept 2018 | - | $933.75 M(+11.0%) |
June 2018 | - | $841.32 M(+4.3%) |
Mar 2018 | - | $806.36 M(-1.4%) |
Dec 2017 | $817.59 M(+123.9%) | $817.59 M(+5.8%) |
Sept 2017 | - | $772.50 M(+2.4%) |
June 2017 | - | $754.09 M(+160.6%) |
Mar 2017 | - | $289.36 M(-20.7%) |
Dec 2016 | $365.09 M(-23.1%) | $365.09 M(-8.5%) |
Sept 2016 | - | $399.16 M(-7.1%) |
June 2016 | - | $429.84 M(-6.4%) |
Mar 2016 | - | $459.33 M(-3.3%) |
Dec 2015 | $474.79 M(+95.4%) | $474.79 M(-3.6%) |
Sept 2015 | - | $492.44 M(-3.7%) |
June 2015 | - | $511.20 M(-3.1%) |
Mar 2015 | - | $527.78 M(+117.2%) |
Dec 2014 | $243.03 M(+57.1%) | $243.03 M(-5.7%) |
Sept 2014 | - | $257.75 M(-4.4%) |
June 2014 | - | $269.54 M(-3.5%) |
Mar 2014 | - | $279.30 M(+80.6%) |
Dec 2013 | $154.68 M(-21.1%) | $154.68 M(-6.8%) |
Sept 2013 | - | $165.97 M(-5.1%) |
June 2013 | - | $174.81 M(-5.0%) |
Mar 2013 | - | $183.92 M(-6.2%) |
Dec 2012 | $195.98 M(+41.6%) | $195.98 M(+1.4%) |
Sept 2012 | - | $193.25 M(-4.4%) |
June 2012 | - | $202.09 M(-3.8%) |
Mar 2012 | - | $210.14 M(+51.9%) |
Dec 2011 | $138.37 M(-4.2%) | $138.37 M(-7.2%) |
Sept 2011 | - | $149.03 M(+17.0%) |
June 2011 | - | $127.41 M(-4.9%) |
Mar 2011 | - | $134.00 M(-7.2%) |
Dec 2010 | $144.42 M | $144.42 M(-3.7%) |
Sept 2010 | - | $149.93 M(-3.3%) |
Date | Annual | Quarterly |
---|---|---|
June 2010 | - | $155.04 M(+94.1%) |
Mar 2010 | - | $79.88 M(+12.8%) |
Dec 2009 | $70.82 M(-40.1%) | $70.82 M(-6.7%) |
Sept 2009 | - | $75.91 M(-12.6%) |
June 2009 | - | $86.87 M(-14.0%) |
Mar 2009 | - | $101.03 M(-14.5%) |
Dec 2008 | $118.18 M(-57.3%) | $118.18 M(-43.1%) |
Sept 2008 | - | $207.73 M(-7.9%) |
June 2008 | - | $225.67 M(-7.5%) |
Mar 2008 | - | $243.88 M(-11.8%) |
Dec 2007 | $276.65 M(-29.0%) | $276.65 M(-12.9%) |
Sept 2007 | - | $317.50 M(-7.1%) |
June 2007 | - | $341.86 M(-6.0%) |
Mar 2007 | - | $363.71 M(-6.7%) |
Dec 2006 | $389.68 M(-19.3%) | $389.68 M(-3.6%) |
Sept 2006 | - | $404.13 M(-8.7%) |
June 2006 | - | $442.54 M(-7.3%) |
Mar 2006 | - | $477.40 M(-1.2%) |
Dec 2005 | $483.12 M(-7.0%) | $483.12 M(-3.6%) |
Sept 2005 | - | $500.97 M(+5.4%) |
June 2005 | - | $475.51 M(-2.2%) |
Mar 2005 | - | $486.37 M(-6.3%) |
Dec 2004 | $519.22 M(-6.4%) | $519.22 M(-6.0%) |
Sept 2004 | - | $552.62 M(+1.1%) |
June 2004 | - | $546.48 M(-5.3%) |
Mar 2004 | - | $577.27 M(+4.0%) |
Dec 2003 | $554.96 M(+108.2%) | $554.96 M(+0.5%) |
Sept 2003 | - | $552.40 M(+48.2%) |
June 2003 | - | $372.76 M(+2.7%) |
Mar 2003 | - | $363.04 M(+36.2%) |
Dec 2002 | $266.54 M(-23.0%) | $266.54 M(-10.7%) |
Sept 2002 | - | $298.64 M(-4.1%) |
June 2002 | - | $311.37 M(-5.2%) |
Mar 2002 | - | $328.29 M(-5.2%) |
Dec 2001 | $346.35 M(+86.2%) | $346.35 M(+94.6%) |
Sept 2001 | - | $177.95 M(+8.8%) |
June 2001 | - | $163.62 M(-5.3%) |
Mar 2001 | - | $172.84 M(-7.1%) |
Dec 2000 | $185.96 M(+70.3%) | $185.96 M(+93.2%) |
Sept 2000 | - | $96.26 M(-1.7%) |
June 2000 | - | $97.91 M(-8.0%) |
Mar 2000 | - | $106.40 M(-2.6%) |
Dec 1999 | $109.20 M(+35.7%) | $109.20 M(+59.9%) |
Sept 1999 | - | $68.30 M(-3.3%) |
June 1999 | - | $70.60 M(-5.4%) |
Mar 1999 | - | $74.60 M(-7.3%) |
Dec 1998 | $80.50 M(-12.4%) | $80.50 M(-7.4%) |
Sept 1998 | - | $86.90 M(+4.1%) |
June 1998 | - | $83.50 M(-5.4%) |
Mar 1998 | - | $88.30 M(-3.9%) |
Dec 1997 | $91.90 M(+17.8%) | $91.90 M(+8.2%) |
Sept 1997 | - | $84.90 M(+1.1%) |
June 1997 | - | $84.00 M(+1.3%) |
Mar 1997 | - | $82.90 M(+6.3%) |
Dec 1996 | $78.00 M | $78.00 M(+8.0%) |
Sept 1996 | - | $72.20 M(-1.6%) |
June 1996 | - | $73.40 M(+161.2%) |
Mar 1996 | - | $28.10 M |
FAQ
- What is Neurocrine Biosciences annual total assets?
- What is the all time high annual total assets for Neurocrine Biosciences?
- What is Neurocrine Biosciences annual total assets year-on-year change?
- What is Neurocrine Biosciences quarterly total assets?
- What is the all time high quarterly total assets for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly total assets year-on-year change?
What is Neurocrine Biosciences annual total assets?
The current annual total assets of NBIX is $3.25 B
What is the all time high annual total assets for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual total assets is $3.25 B
What is Neurocrine Biosciences annual total assets year-on-year change?
Over the past year, NBIX annual total assets has changed by +$882.70 M (+37.27%)
What is Neurocrine Biosciences quarterly total assets?
The current quarterly total assets of NBIX is $3.54 B
What is the all time high quarterly total assets for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly total assets is $3.54 B
What is Neurocrine Biosciences quarterly total assets year-on-year change?
Over the past year, NBIX quarterly total assets has changed by +$686.80 M (+24.11%)